CONCORD BIOTECH share price has zoomed 10% and is presently trading at Rs 1,779.6.
Meanwhile, the BSE HEALTHCARE index is at 42,959.7 (up 0.5%).
Among the top gainers in the BSE HEALTHCARE index today are ERIS LIFESCIENCES (up 2.6%) and Biocon (up 1.2%).
Procter & Gamble Health (down 1.2%) and ALEMBIC PHARMA (down 0.8%) are among the top losers today.
Over the last one year, CONCORD BIOTECH has moved up from Rs 997.2 to Rs 1,779.6, registering a gain of Rs 782.5 (up 78.5%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,859.6 to 42,959.7, registering a gain of 54.2% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 136.1%), Glenmark Pharma (up 122.7%) and SUVEN PHARMACEUTICALS (up 107.5%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 81,858.3 (up 0.1%).
The top gainers among the BSE Sensex today are Sun Pharma (up 0.6%) and HDFC Bank (up 0.5%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 25,054.3 . Cipla and Bajaj Auto are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 64,996.6 to 81,858.3, registering a gain of 16,861.7 points (up 25.9%).
CONCORD BIOTECH net profit grew 20.2% YoY to Rs 582 million for the quarter ended June 2024, compared to a profit of Rs 485 million a year ago. Net sales rose 10.8% to Rs 2,158 million during the period as against Rs 1,948 million in April-June 2023.
For the year ended March 2024, CONCORD BIOTECH reported 28.3% increase in net profit to Rs 3,081 million compared to net profit of Rs 2,401 million during FY23. Revenue of the company grew 19.2% to Rs 10,169 million during FY24.
The current Price to earnings ratio of CONCORD BIOTECH, based on rolling 12 month earnings, stands at 59.2.
Equitymaster requests your view! Post a comment on "CONCORD BIOTECH Gains 10%; BSE HEALTHCARE Index Up 0.5%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!